Treasury Secretary Scott Bessent champions the new 'Trump Accounts' as a crucial savings tool for future generations, brushing aside concerns they may exacerbate inequality. The program gains momentum with backing from JPMorgan, Bank of America, and high-profile philanthropists.
Data security leader Commvault Systems saw its stock price collapse to a 52-week low following its Q3 report, a stark contrast to its strong revenue and earnings beat. The sell-off highlights investor sensitivity to valuation and future guidance in a cooling software sector.
Social Security was designed as one component of a broader retirement strategy, not a standalone solution. For average earners, benefits typically replace about 40% of pre-retirement income, but experts urge personal savings to fill the gap.
While Riverview Rubber Estates Berhad's share price has declined 12% over three years, trailing the broader market's 26% gain, its total shareholder return tells a more nuanced story. Including dividends, investors would have seen a modest 1.9% return, highlighting the critical role of income in long-term portfolio performance.
Despite a mixed earnings report, Texas Instruments stock surged over 11% this week, powered by explosive growth in its data center business as AI demand fuels infrastructure spending.
Covenant Logistics Group struck a cautiously optimistic note in its Q4 2025 earnings call, citing improving freight fundamentals and rising bid activity, even as margin compression across key segments weighed on profits. The company is navigating the shift through fleet optimization, a reduced capex plan, and the integration of a new brokerage unit.
First Hawaiian Bank reported a solid fourth quarter, driven by net interest margin expansion and loan growth, while outlining a cautious 2026 outlook. Executives highlighted Hawaii's resilient economy and strong credit quality, alongside a new, flexible $250 million share buyback program.
Citi analyst Geoff Meacham raised his price target on Bristol-Myers Squibb (BMY) to $60, citing a more favorable setup for the sector. The move comes as the drugmaker also announces a partnership with Microsoft to leverage AI for earlier lung cancer detection.
As a surge in data center demand strains the PJM Interconnection grid, planners unveil a strategy to fast-track connections while wrestling with supply chain delays that threaten to outpace new power generation. Experts warn of a looming mismatch between market promises and construction realities.
Shares of Heidelberg Materials have delivered stellar returns, more than tripling over three years. As the stock consolidates near recent highs, investors are questioning whether the rally has priced in future growth or if significant value remains. A deep dive into valuation metrics suggests the latter.
Barrick Gold's stock has soared over 220% in the past year, leaving investors to question if the rally has peaked. A deep dive into valuation metrics suggests the mining giant may still be trading at a significant discount to its intrinsic value.
Microsoft's free cash flow took a significant hit last quarter due to soaring capital expenditures on AI infrastructure. While the drop spooked some investors, management signals a near-term easing, and analysts argue the market's reaction may have overlooked the long-term payoff and underlying financial strength.
Oracle shares face continued pressure over debt and AI infrastructure costs, but Guggenheim's bullish $400 price target suggests potential for a multi-year rebound if execution risks are managed.
As a temporary halt in Russian airstrikes on Kyiv brokered by former U.S. President Trump nears its end, Ukraine is urgently working to strengthen its air defenses. Analysts caution the lull may be a tactical move by Moscow to bolster its diplomatic leverage rather than a step toward peace.
Despite recent downgrades from two major Wall Street firms, analysts maintain that Nutanix (NTNX) shares hold substantial upside potential, even as questions emerge about the pace of its near-term growth.
Despite a bruising year, XRP's legal clarity, banking ambitions, and technical upgrades position it as a speculative recovery play for investors eyeing the next market cycle.
While the healthcare sector has surged 17.4% in six months, outpacing the S&P 500, regulatory headwinds and valuation concerns demand a selective approach. We examine one stock with a durable edge and two facing significant challenges.
While the small-cap index is a hunting ground for growth, some constituents face significant headwinds. We examine three companies where valuation and market dynamics warrant a cautious approach.
While low-volatility stocks promise stability in turbulent markets, experts warn that their defensive appeal may mask underlying risks and missed opportunities for growth. We examine three such companies that investors might want to approach with caution.
Altria Group (MO) posted stronger-than-expected Q4 revenue, driven by its core tobacco brands and oral nicotine products, but saw its shares fall as profit margins contracted sharply. The company is betting on a national rollout of its ON! Plus pouches and manufacturing upgrades to fuel its smoke-free future.
